Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Genes and hormones cause hair loss, with four genes contributing equally.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

Different types of fibroblasts play various roles in both healthy and diseased tissues, and understanding them better could improve treatments for fibrotic diseases.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The study explains how minoxidil sulfate causes vasodilation in rabbits by opening potassium channels and inhibiting calcium channels.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Melatonin improved mental health and metabolism in women with PCOS.

*Acorus calamus* has many medicinal benefits but needs more safety research.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Trichoscopy is a non-invasive way to diagnose hair and scalp problems without needing hair samples.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Long-term minoxidil use can cause pseudoacromegaly, but stopping it improves symptoms.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.